Kerri-Ann Millar

Insider Reports History

Location
Boston, MA
Signature
/s/ Kerri-Ann Millar by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kerri-Ann Millar:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 200,000 21 Mar 2025 Direct

Insider Reports Filed by Kerri-Ann Millar

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 21 Mar 2025 1 $0 4 CHIEF FINANCIAL OFFICER 25 Mar 2025, 16:00
CUE Cue Biopharma, Inc. 05 Jun 2024 1 $0 4 CHIEF FINANCIAL OFFICER 07 Jun 2024, 16:00
CUE Cue Biopharma, Inc. 06 Mar 2024 1 $0 4 CHIEF FINANCIAL OFFICER 08 Mar 2024, 16:00
CUE Cue Biopharma, Inc. 21 Jul 2023 1 $0 4 CHIEF FINANCIAL OFFICER 25 Jul 2023, 12:31
CUE Cue Biopharma, Inc. 16 Feb 2023 1 $0 4 CHIEF FINANCIAL OFFICER 21 Feb 2023, 15:58
CUE Cue Biopharma, Inc. 21 Aug 2022 3 -$8,625 4 CHIEF FINANCIAL OFFICER 23 Aug 2022, 16:03
CUE Cue Biopharma, Inc. 09 Feb 2022 2 $0 4 CHIEF FINANCIAL OFFICER 29 Mar 2022, 16:05
CUE Cue Biopharma, Inc. 23 Aug 2021 6 -$8,400 4 CHIEF FINANCIAL OFFICER 05 Oct 2021, 19:21